Equipment and Ancillary Materials Supply


Expense Reimbursement Services are designed to meet legislation of Ukraine and EU Clinical Trial Directive (2001/20/EC) and Regulation (536/2014) that states: no incentives or financial inducements are given to incapacitated participants or minors (or either of their legally designated representatives), or to pregnant women, except for compensation for expenses and loss of earnings directly related to participation in the clinical trial.

While the number of clinical trials in Ukraine increasing and their efficiency and quality as well, patient recruitment and retention becomes more crucial.

The success of the trial depends on identifying the right patients for the study and their further engagement to invest their time and effort into drug development. Patient recruitment is considered to be one of the most difficult challenges and it is estimated that 80% of clinical trials do not meet their patient enrolment deadlines.

What is more, our flexibility and transparent accountancy will benefit you in a cost-effectiveness while we can suggest many options with an adequate location and venue to avoid unexpected and irrational expenses to meet your budget requirement.

Effective investigator meeting is an important part of every clinical trial allowing transforming individual healthcare professionals into a coherent study team. Everyone needs to be on the same page regarding the clinical trial’s purpose, protocols, participant enrollment criteria, safety issues, and more. 

When onboarding IRM, you will be able to create an experience that leaves site staff well trained, motivated, ready to enroll patients, and able to effectively solve problems that may arise. If you’re looking for ways to increase engagement and drive true value from your meetings, please do not hesitate to contact us.

We offer live, virtual or hybrid events with accommodation of customer’s requirements or policies to meeting, travel, privacy and data protection.

Contact us for a free consultation

Receive more details